Asian patients with newly diagnosed acute myeloid leukemia (AML) may have superior overall survival (OS) outcomes compared with White patients, though further data are needed to corroborate this ...

Intraoral photobiomodulation therapy reduced severe oral mucositis and other adverse effects of radiation therapy in patients with HNC.

The use of a virtual reality device significantly improved depression and anxiety in patients with cancer preparing for radiotherapy.

Symptom control and quality of life is improved for patients with head and neck cancer when patient-reported outcomes are monitored throughout care.

Trastuzumab deruxtecan continues to demonstrate superior safety and efficacy compared with trastuzumab emtansine in patients with high-risk, HER2-positive early breast cancer who have residual ...

A recent study shows a regimen of low-dose homoharringtonine, cytarabine, and G-CSF (HAG) is an effective and promising treatment for pediatric patients with AML.

Investigators evaluated atezolizumab combined with bevacizumab and non–platinum-based chemotherapy for patients with recurrent ovarian cancer.

Researchers developed and validated a machine-learning algorithm for predicting nutritional risk in patients with nasopharyngeal carcinoma.

The phase 3, open-label, single arm BOND-003 trial also evaluated cretostimogene in cohort P with papillary-only high-grade NMIBC who failed prior BCG therapy.

In this retrospective study, researchers aimed to characterize persistent toxicities experienced by patients with TNBC who were treated with pembrolizumab in the curative setting.

HealthDay News — Among adults aged 45 to 49 years who are newly eligible for colorectal cancer (CRC) screening, there are no significant differences in screening uptake in adjusted analyses, according ...

Researchers compared the safety and efficacy of BrECADD vs eBEACOPP, a standard regimen, in the newly diagnosed, advanced-stage classical HL setting.